newsfilter
← Latest News
Business Wire·

Sage Therapeutics Announces R&D Leadership Transition

Sage Therapeutics, Inc. (NASDAQ:SAGE) today announced that Dr. Laura Gault, Chief Medical Officer, has decided to pursue a new opportunity and will depart the Company, effective March 21, 2025. Dr. Gault joined Sage